Notably, IDO inhibitors, such as 1‐methyltryptophan and epigallocatechin gallate, have demonstrated efficacy in preventing the formation of colonic preneoplastic lesions, representing a novel strategy for colon cancer prevention [87]. The gene discussed is IDO1; the disease is malignant colon neoplasm.